Winton Group’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-103,111
| Closed | -$7.41M | – | 1242 |
|
|
2026
Q1 | $7.41M | Buy |
+103,111
| New | +$7.94M | 0.26% | 82 |
|
|
2025
Q2 | – | Sell |
-13,985
| Closed | -$947K | – | 858 |
|
|
2025
Q1 | $947K | Buy |
+13,985
| New | +$837K | 0.06% | 436 |
|
|
2024
Q2 | – | Sell |
-3,666
| Closed | -$292K | – | 605 |
|
|
2024
Q1 | $292K | Sell |
3,666
-32,983
| -90% | -$2.52M | 0.02% | 528 |
|
|
2023
Q4 | $2.89M | Sell |
36,649
-13,520
| -27% | -$962K | 0.21% | 72 |
|
|
2023
Q3 | $3.5M | Buy |
+50,169
| New | +$3.55M | 0.29% | 60 |
|
|
2023
Q2 | – | Sell |
-9,559
| Closed | -$710K | – | 847 |
|
|
2023
Q1 | $710K | Buy |
+9,559
| New | +$802K | 0.04% | 561 |
|
|
2022
Q4 | – | Sell |
-6,384
| Closed | -$609K | – | 943 |
|
|
2022
Q3 | $609K | Sell |
6,384
-15,397
| -71% | -$1.52M | 0.04% | 581 |
|
|
2022
Q2 | $2.02M | Buy |
21,781
+13,620
| +167% | +$1.33M | 0.11% | 259 |
|
|
2022
Q1 | $826K | Sell |
8,161
-9,706
| -54% | -$1.02M | 0.04% | 530 |
|
|
2021
Q4 | $1.84M | Buy |
+17,867
| New | +$1.65M | 0.11% | 250 |
|
|
2020
Q3 | – | Sell |
-23,390
| Closed | -$1.52M | – | 1498 |
|
|
2020
Q2 | $1.52M | Buy |
+23,390
| New | +$1.47M | 0.04% | 778 |
|
|
2019
Q2 | – | Sell |
-3,832
| Closed | -$207K | – | 1159 |
|
|
2019
Q1 | $207K | Sell |
3,832
-1,741
| -31% | -$107K | ﹤0.01% | 953 |
|
|
2018
Q4 | $365K | Buy |
5,573
+198
| +4% | +$14.8K | 0.01% | 590 |
|
|
2018
Q3 | $423K | Sell |
5,375
-102,919
| -95% | -$7.36M | 0.01% | 695 |
|
|
2018
Q2 | $6.97M | Buy |
108,294
+46,128
| +74% | +$3.04M | 0.18% | 210 |
|
|
2018
Q1 | $3.87M | Sell |
62,166
-2,582
| -4% | -$185K | 0.11% | 245 |
|
|
2017
Q4 | $4.69M | Sell |
64,748
-28,835
| -31% | -$2.1M | 0.14% | 277 |
|
|
2017
Q3 | $7.61M | Sell |
93,583
-126,167
| -57% | -$9.98M | 0.24% | 108 |
|
|
2017
Q2 | $17.7M | Sell |
219,750
-70,701
| -24% | -$5.58M | 0.52% | 47 |
|
|
2017
Q1 | $22.8M | Buy |
290,451
+161,789
| +126% | +$12.9M | 0.62% | 44 |
|
|
2016
Q4 | $10.2M | Buy |
128,662
+4,584
| +4% | +$371K | 0.34% | 96 |
|
|
2016
Q3 | $11M | Buy |
124,078
+105,660
| +574% | +$9.97M | 0.19% | 176 |
|
|
2016
Q2 | $1.76M | Sell |
18,418
-353,111
| -95% | -$35.2M | 0.03% | 265 |
|
|
2016
Q1 | $38.5M | Sell |
371,529
-182,275
| -33% | -$17.7M | 0.42% | 98 |
|
|
2015
Q4 | $54.1M | Buy |
553,804
+17,325
| +3% | +$1.7M | 0.48% | 72 |
|
|
2015
Q3 | $51.8M | Buy |
536,479
+337,973
| +170% | +$35.5M | 0.41% | 82 |
|
|
2015
Q2 | $20.8M | Buy |
198,506
+157,636
| +386% | +$16.1M | 0.19% | 190 |
|
|
2015
Q1 | $4.22M | Sell |
40,870
-95,737
| -70% | -$9.69M | 0.03% | 356 |
|
|
2014
Q4 | $13.2M | Sell |
136,607
-644,656
| -83% | -$56.8M | 0.16% | 220 |
|
|
2014
Q3 | $62.2M | Sell |
781,263
-189,224
| -19% | -$14.9M | 0.44% | 59 |
|
|
2014
Q2 | $73.1M | Buy |
+970,487
| New | +$73.3M | 0.5% | 38 |
|
Other funds holding CVS
Winton Group's CVS Position: Q2 2026 in Review
Winton Group sold out of CVS Health (CVS) in Q2 2026, closing a stake of 103,111 shares — an estimated $7.41M sold.
Winton Group first reported a position in CVS in Q2 2014 and held it in 31 quarters. The position peaked at $73.1M in Q2 2014. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- Winton Group reported no remaining CVS Health position as of Q2 2026 after selling out during the quarter.
- Winton Group sold 103,111 CVS Health shares in Q2 2026, an estimated $7.41M.
- Winton Group first reported a position in CVS Health in Q2 2014 and held it in 31 quarters.
- Winton Group's CVS Health position peaked at $73.1M in Q2 2014.
- 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on Winton Group's 13F filing for Q2 2026, filed 7 Aug 2026.